The healthcare world is observing a significant shift in blood sugar therapy with the arrival of GLP-1 skin applications. These systems offer a potentially more comfortable alternative to injections of GLP-1 receptor agonists, lessening the need for daily needle pricks. The approach administers the compound directly through the surface, arguably bo